Selective aortic arch perfusion

Details Selective aortic arch perfusion Selective aortic arch perfusion

1994-03-30

1995-08-01

Rosenbaum, C. Fred

Surgery

Means for introducing or removing material from body for...

Treating material introduced into or removed from body...

128898, 514716, 514718, A61M 3100

Patent

active

054376335

ABSTRACT:
A method of treating a subject in cardiac arrest, comprises blocking the descending aorta of the subject and then perfusing the aortic arch of the subject with a protective solution. The protective solution is one capable of delivering oxygen to the heart of said subject, such-as a perfluorochemical blood substitute. Following perfusion, spontaneous circulation is restored.
In an improved embodiment of the foregoing, a vasoconstrictor such as epinephrine is administered concurrently with the perfusing step in an amount effective to enhance coronary perfusion with said protective solution.

REFERENCES:
patent: 3962439 (1976-06-01), Yokoyama et al.
patent: 4686085 (1987-08-01), Osterholm
patent: 5085630 (1992-02-01), Osterholm
patent: 5216032 (1993-06-01), Manning
patent: 5334142 (1994-08-01), Paradis
R. J. Novick, et al.; Protection of the hypertrophied pig myocardium, Journal of Thoracic and Cardiovascular Surgery 89 pp. 547-566, (1985).
C. S. Goodman and A. Gilman; the Pharmacological Basis of Therapeutics, Macmillan Publishing Company Seventh Edition pp. 716-718 (1985).
SU, A., Mosc. Medical Inst. Abstract 28 Feb. 1984.
G. B. Martin et al.; Aortic and Right Atrial Pressures During Standard and Simultaneous Compression and Ventillation CPR in Human Beings, Annals of Emergency Medicine pp. 125/37-130/42 (Feb. 1986).
M. Cleman, et al.; Prevention of ischemia during precutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%, Therapy and Prevention Coronary Angioplasty 74, pp. 555-562 (1986).
A. Martin, et al.; Physical Chemical Principles in the Pharmaceutical Science, Physical Pharmacy, pp. 276-277 (1988).
The Merck Index, Eleventh Edition (1989).
A. K. Bajaj, et al; Limitation of Myocardial REperfusion Injury by Intravenous Perfluorochemicals, Circulation 79, pp. 645-656 (1989).
C. L. Emerman, et al; Hemodynamic Effects of the Intra-aortic Balloon Pump During Experimental Cardiac Arrest, Am. J. Emerg. Med. 7 (1989).
H. Memezawa et al.; Effects of Fluosol-DA on Brain Edema, Energy Metabolites, and Tissue Oxygen Content in Acute Cerebral Ischemia, Advances in Neurology 52, pp. 109 -118 (1990).
L. B. Becker et al.; Outcome of CPR in a Large Metropolitan Area-Where are the Survivors?, Annals of Emergency Medicine, pp. 48/355-54/361 (1990).
J. E. Manning et al; Selective Aortic Arch Perfusion During Cardiac Arrest: Rapid Aortic Arch Pressurization is Required to Consistently Achieve Competent Aortic Valve Closure and Coronary-Perfusion, Abstract.

Affiliated with

Also associated with

Rating

Selective aortic arch perfusion does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Selective aortic arch perfusion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective aortic arch perfusion will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-731027